Kirby Institute Seminar Series presents
In contrast to many settings, people who inject drugs (PWID) in the Netherlands do not play a substantial role in the current spread of HIV and other blood-borne infections. The early implementation of harm-reduction programs (HRP) (i.e. opiate substitution therapy [OST] and needle and syringe exchange programs [NSP]) might have contributed to declining incidence of these infections over time. Using data from the Amsterdam Cohort Studies with over 30 years of follow up, we assessed the causal effect of HRP on HIV, hepatitis C and hepatitis B infection risk among PWID.